This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Edward H. Liston, MD; Martin D. Levine, MD; Michel Philippart, MD

Arch Gen Psychiatry. 1973;29(3):402-403.

Abstract
The first known reported occurrence of psychosis in Fabry disease is presented. Of considerable interest is the observation that treatment with the -adrenergic blocking agent phenoxybenzamine hydrochloride (Dibenzyline) was related quite unexpectedly to remission of psychotic signs and symptoms on two separate occasions. This finding suggests that the drug acted as an antipsychotic agent in this patient. Whether the mechanism of action was related to its sympatholytic properties, its neuroleptic effects, or to other, unknown actions is not clear.

Author Affiliations
Los Angeles

From the Neuropsychiatric Institute and the departments of psychiatry (Drs. Liston, Levine, and Philippart), neurology (Drs. Levine and Philippart), and pediatrics (Dr. Philippart), University of California School of Medicine, Los Angeles.

Footnotes
Accepted for publication April 10, 1973.

Reprint requests to University of California School of Medicine, Center for the Health Sciences, 760 Westwood Plaza, Los Angeles, CA 90024 (Dr. Liston).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Differential Diagnosis of Childhood- and Young Adult-Onset Disorders That Include Psychosis
Lauterbach et al.
J. Neuropsychiatry Clin. Neurosi. 2008;20:409-418.
ABSTRACT | FULL TEXT